Neostigmine Methylsulfate (Cantrell Drug Company)
Welcome to the PulseAid listing for the Neostigmine Methylsulfate drug offered from Cantrell Drug Company. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cantrell Drug Company |
| NON-PROPRIETARY NAME: | Neostigmine Methylsulfate |
| SUBSTANCE NAME: | NEOSTIGMINE METHYLSULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2015-02-03 |
| END MARKETING DATE: | 0000-00-00 |
Neostigmine Methylsulfate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Neostigmine Methylsulfate from Cantrell Drug Company |
| LABELER NAME: | Cantrell Drug Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2015-02-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52533-046_21a6eba5-688b-4333-9b1f-63f5323a19e8 |
| PRODUCT NDC: | 52533-046 |
| APPLICATION NUMBER: | |
Other NEOSTIGMINE METHYLSULFATE Pharmaceutical Manufacturers / Labelers:
